Caitong International Asset Management Co. Ltd Increases Position in Tilray Brands, Inc. $TLRY

Caitong International Asset Management Co. Ltd increased its stake in shares of Tilray Brands, Inc. (NASDAQ:TLRY) by 99,204,800.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 992,049 shares of the company’s stock after purchasing an additional 992,048 shares during the quarter. Tilray Brands makes up 1.2% of Caitong International Asset Management Co. Ltd’s holdings, making the stock its 13th largest position. Caitong International Asset Management Co. Ltd owned 0.09% of Tilray Brands worth $1,716,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in TLRY. AQR Capital Management LLC lifted its position in shares of Tilray Brands by 1,839.7% during the first quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock valued at $399,000 after buying an additional 575,757 shares during the last quarter. Swiss National Bank raised its stake in shares of Tilray Brands by 6.1% during the 2nd quarter. Swiss National Bank now owns 1,928,138 shares of the company’s stock worth $799,000 after acquiring an additional 111,500 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Tilray Brands during the 2nd quarter worth approximately $112,000. J.W. Cole Advisors Inc. lifted its position in Tilray Brands by 203.2% during the second quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock valued at $30,000 after acquiring an additional 48,177 shares during the last quarter. Finally, Cerity Partners LLC lifted its position in Tilray Brands by 98.5% during the second quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock valued at $38,000 after acquiring an additional 45,929 shares during the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Brands Price Performance

Shares of TLRY opened at $6.95 on Wednesday. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.81 and a quick ratio of 1.72. The company’s fifty day moving average price is $7.98 and its 200-day moving average price is $10.65. Tilray Brands, Inc. has a 1-year low of $3.51 and a 1-year high of $23.20. The firm has a market capitalization of $809.74 million, a PE ratio of -0.31 and a beta of 1.96.

Tilray Brands (NASDAQ:TLRY) last issued its quarterly earnings results on Thursday, January 8th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.12. The company had revenue of $217.51 million during the quarter, compared to analysts’ expectations of $211.15 million. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.During the same quarter in the previous year, the firm posted ($0.03) EPS. On average, equities research analysts predict that Tilray Brands, Inc. will post -0.2 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on TLRY. Roth Mkm cut their price target on shares of Tilray Brands from $20.00 to $10.00 and set a “neutral” rating on the stock in a report on Tuesday, January 20th. Wall Street Zen downgraded Tilray Brands from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Zacks Research raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, January 21st. Finally, Canaccord Genuity Group began coverage on Tilray Brands in a report on Tuesday, January 27th. They issued a “hold” rating for the company. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $13.33.

Key Stories Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray entered an asset purchase agreement to acquire key U.S. BrewDog assets — including the Columbus, Ohio brewery, a branded hotel, several pubs (Ohio, Las Vegas, Denver) and an airport location — expanding its U.S. craft-beer footprint and consumer-facing distribution. Tilray Brands Enters Agreement to Acquire BrewDog’s Key U.S. Assets
• Positive Sentiment: A sell-side upgrade framed Tilray’s larger “big bet on beverages” as a catalyst — analysts are now reframing the company as a consumer packaged-goods and beverage play, which can drive multiple re-rating if execution and margin mix improve. Tilray: Big Bet On Beverages (Rating Upgrade)
• Neutral Sentiment: Local-market acceptance may smooth integration: coverage notes BrewDog’s strong following in Ohio and that Tilray already sells cannabis-infused drinks, which could create cross‑sell or experiential opportunities at the acquired pubs. BrewDog’s US operations sold to new owner. What does that mean for Ohio?
• Neutral Sentiment: Commentary pieces highlight that Tilray’s diversification into beverages is strategic but long‑term; benefits depend on integration, brand management and margin expansion rather than immediate EPS upside. Will Tilray Brands’ Diversification Strategy Pay Off for Investors?
• Negative Sentiment: Deal economics were undisclosed and BrewDog has been described as a struggling seller — that raises short-term execution risk, potential capital outlay, and integration costs; Tilray remains unprofitable on margins and below its 50/200-day technical averages, which tempers upside. Tilray Quenches Thirst For U.S. Beer Assets With BrewDog Deal

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.